These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6675899)

  • 1. Impact of the Coronary Drug Project findings on clinical practice.
    Friedman L; Wenger NK; Knatterud GL
    Control Clin Trials; 1983 Dec; 4(4):513-22. PubMed ID: 6675899
    [No Abstract]   [Full Text] [Related]  

  • 2. The Coronary Drug Project. Experimental design features.
    Canner PL; Klimt CR
    Control Clin Trials; 1983 Dec; 4(4):313-32. PubMed ID: 6675887
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief description of the Coronary Drug Project and other studies.
    Canner PL
    Control Clin Trials; 1983 Dec; 4(4):273-80. PubMed ID: 6373137
    [No Abstract]   [Full Text] [Related]  

  • 4. Current practice in the use of anticoagulants for ischemic heart disease: a survey of 200 hospitals.
    Bassan MM; Rogel S
    Heart Lung; 1976; 5(5):742-6. PubMed ID: 1048945
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiplatelet agents prevent cardiac events in patients with coronary artery disease.
    Ishikawa K
    Intern Med; 1998 Feb; 37(2):199-202. PubMed ID: 9550609
    [No Abstract]   [Full Text] [Related]  

  • 6. The Coronary Drug Project. External quality control programs.
    Canner PL; Krol WF; Forman SA
    Control Clin Trials; 1983 Dec; 4(4):441-66. PubMed ID: 6675895
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiplatelet therapy: a perspective from cardiology.
    Zusman RM
    Manag Care; 2000 Oct; 9(10 Suppl):5-8. PubMed ID: 11729421
    [No Abstract]   [Full Text] [Related]  

  • 8. The Coronary Drug Project. Role and methods of the Drug Procurement and Distribution Center.
    Brennan EC
    Control Clin Trials; 1983 Dec; 4(4):409-17. PubMed ID: 6675892
    [No Abstract]   [Full Text] [Related]  

  • 9. Underutilization of beta-adrenoceptor antagonists post-myocardial infarction.
    Gutierrez ME; Labovitz AJ
    Am J Cardiovasc Drugs; 2005; 5(1):23-9. PubMed ID: 15631535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. We must use the knowledge that we have to treat patients with acute coronary syndromes.
    White HD; Willerson JT
    Circulation; 2004 Feb; 109(6):698-700. PubMed ID: 14970103
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the emperor really wearing new clothes? Informed consent for acute coronary syndromes.
    Sugarman J
    Am Heart J; 2000 Jul; 140(1):2-3. PubMed ID: 10874252
    [No Abstract]   [Full Text] [Related]  

  • 12. The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
    Stamler J
    Adv Exp Med Biol; 1977; 82():52-75. PubMed ID: 335823
    [No Abstract]   [Full Text] [Related]  

  • 13. The coronary drug project. Design, methods, and baseline results.
    Circulation; 1973 Mar; 47(3 Suppl):I1-50. PubMed ID: 4570454
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation in coronary heart disease: heparin and warfarin trials.
    Lopez LM; Mehta JL
    Cardiovasc Clin; 1987; 18(1):215-29. PubMed ID: 2955891
    [No Abstract]   [Full Text] [Related]  

  • 15. Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group.
    Canner PL; Halperin M
    Circulation; 1981 Jun; 63(6):1342-50. PubMed ID: 7014029
    [No Abstract]   [Full Text] [Related]  

  • 16. [Corontin in coronary disease].
    Tokarz J; Janicki K
    Wiad Lek; 1966 Apr; 19(8):637-9. PubMed ID: 5329017
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of anticoagulant therapy in acute myocardial infarction.
    Goldberg RJ; Gore JM; Dalen JE
    Am Heart J; 1984 Nov; 108(5):1387-93. PubMed ID: 6388296
    [No Abstract]   [Full Text] [Related]  

  • 18. [General aspects of a project of a controlled clinical experimentation with coronary-active drug, evaluated on the base of the onset of remission of signs and symptoms].
    Rocchi P; Cavrini P
    Boll Chim Farm; 1972 Sep; 111(9):579-82. PubMed ID: 4565804
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blockers and myocardial infarction: infarction and ischaemia in the practolol and propranolol trials.
    Green KG; Baber NS; Lewis JA
    Aust N Z J Med; 1983 Apr; 13(2):181-2. PubMed ID: 6137206
    [No Abstract]   [Full Text] [Related]  

  • 20. Managers & medicine: treatment guide.
    Health Serv J; 2002 Mar; 112(5798):38. PubMed ID: 12001900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.